Filter
2001
Filtered Results: 2001
Text search:
Mental
Health
America
Featured
Recommendations
183
New Publications
294
Language
Document type
No document type
987
Studies & Reports
441
Guidelines
257
Manuals
145
Strategic & Response Plan
57
Training Material
48
Fact sheets
24
Situation Updates
17
Resource Platforms
10
Brochures
7
Online Courses
4
Infographics
3
App
1
Countries / Regions
Latin America and the Carribbean
172
Global
131
India
38
Western and Central Europe
33
Venezuela
28
Brazil
26
South Africa
24
Indonesia
23
Ukraine
19
Colombia
18
Syria
17
Ethiopia
15
Kenya
14
Africa
14
Russia
14
Chile
13
Peru
13
Haiti
13
Paraguay
13
Uganda
13
Myanmar / Burma
13
Nigeria
12
Ecuador
12
Philippines
11
Asia
10
Zambia
10
Liberia
10
Tanzania
9
West and Central Africa
9
South–East Asia Region
9
Bangladesh
9
Eastern Europe
9
Ghana
8
Sierra Leone
8
Rwanda
8
Germany
8
Middle East and North Africa
8
Argentina
8
South Sudan
8
Nepal
7
Zimbabwe
7
Mozambique
7
East and Southern Africa
7
Bolivia
7
USA
6
Eastern Europe and Central Asia
6
Yemen
6
China
5
Afghanistan
5
Malawi
5
Guinea
5
Cambodia
5
Congo, Democratic Republic of
5
North America
5
Namibia
5
Botswana
5
Somalia
5
Eswatini/ Swaziland
5
Canada
4
Spain
4
Greece
4
Angola
4
Guatemala
4
Tajikistan
3
Thailand
3
Mexico
3
El Salvador
3
Jamaica
3
Nicaragua
3
Moldova
3
Sudan
3
Pakistan
3
Lesotho
2
Benin
2
Kazakhstan
2
Cameroon
2
Senegal
2
Malaysia
2
Portugal
2
Sri Lanka
2
Honduras
2
North Macedonia
1
Timor Leste/ East Timor
1
Turkey
1
Iran
1
Albania
1
Singapore
1
Laos
1
Estonia
1
Kyrgyzstan
1
Burkina Faso
1
Burundi
1
Armenia
1
Guinea-Bissau
1
Lithuania
1
Jordan
1
Ireland
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
Belgium
1
Belarus
1
French Guyana
1
Egypt
1
Romania
1
Georgia
1
Central African Republic
1
Poland
1
Libya
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
452
Women & Child Health
146
Clinical Guidelines
144
Public Health
125
Key Resources
101
Capacity Building
32
Pharmacy & Technologies
14
Annual Report MEDBOX
3
Toolboxes
Mental Health
473
COVID-19
207
HIV
162
Disability
117
Planetary Health
113
TB
65
Caregiver
55
Global Health Education
54
NTDs
50
Refugee
47
Conflict
45
NCDs
38
Ebola & Marburg
24
Health Financing Toolbox
24
Rapid Response
23
Pharmacy
22
Natural Hazards
18
Social Ethics
18
Zika
18
Specific Hazards
15
Malaria
11
AMR
9
2.0 Rapid Response
8
Cholera
7
Polio
2
Men lag behind women regarding use of HIV services and represent the majority of individuals living with uncontrolled HIV, advanced HIV, and who experience HIV-related mortality. Men (15+) globally are less likely than women (15+) to know their HIV status (83% for men vs 91% for women), be on antire...
Global Campaign Against Epilepsy
A resource for pesticide registrars and regulators.
The WHO urged governments to restrict access to highly toxic pesticides used for self-poisoning . Other effective interventions include education, youth intervention programs and follow-up of people at risk—and better data. Only 80 out of 183 WH...
This year marked the beginning of the WHO biennium 2016-2017 action plan; this annual report highlights WHO’s key achievements in 2016
It also documents the extraordinary efforts by a broad coalition of government ministries, municipalities, international agencies, community groups, women’s or...
16-24 February 2020
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
The objectives of this guideline are the same as those of the 2011 edition, namely to provide evidence-based normative guidance on interventions to improve adolescent morbidity and mortality by reducing the chances of early pregnancy and its resulting poor health outcomes. The specific objectives of...
This document is for public health specialists, health emergency responders, clinicians, health facility managers, health and care workers and IPC practitioners including but not limited to those working in primary care clinics, sexual health clinics, emergency departments, dental practices, infecti...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This policy brief presents a summary of current evidence on vulnerability to TB and proposes interventions for equitable, person-centred, and human rights-based TB prevention and care. It aligns with WHO policies and guidance on TB prevention and screening, management of TB and comorbidities, access...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amphetamines and others with identified or emergent cl...
Global Health Estimates
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
